Chronic pain clinical trials

Explore recruiting chronic pain clinical trials.

Recruiting chronic pain studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic pain trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) once weekly versus placebo in participants with type 2 diabetes and painful diabetic peripheral neuropathy

Norway, Denmark, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, double dummy, placebo-controlled, four-way cross-over study to investigate the analgesic effects and CNS effects of morphine and fluvoxamine in healthy subjects.

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

A clinical study of MK-5661 in healthy people (MK-5661-007)

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Efficacy of perioperative duloxetine in patients at high risk for developing chronic postsurgical pain after inguinal hernia repair: a multicenter randomized controlled trial

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A clinical study of MK-5661 and placebo in healthy people (MK-5661-006)

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

Research into new test methods to measure pain with two existing drugs (nefopam and oxycodone)

Netherlands

Human Pharmacology (Phase I)- Other EU CTIS Study details

Chronic pain trials by city

Chronic pain in Toronto Chronic pain in Vancouver Chronic pain in Montreal Chronic pain in Calgary Chronic pain in Edmonton Chronic pain in Ottawa Chronic pain in Winnipeg Chronic pain in Quebec City Chronic pain in Hamilton Chronic pain in Kitchener Chronic pain in London Chronic pain in Halifax Chronic pain in New York Chronic pain in Los Angeles Chronic pain in Chicago Chronic pain in Houston

Other conditions

Glaucoma Dry eye disease HIV Hepatitis B Hepatitis C COVID-19 Influenza RSV Sickle cell disease Anemia Hemophilia Thalassemia Low back pain Smoking cessation Tinnitus Hearing loss Chronic fatigue syndrome Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol